Literature DB >> 30705095

CD371 cell surface expression: a unique feature of DUX4-rearranged acute lymphoblastic leukemia.

Dagmar Schinnerl1, Ester Mejstrikova2,3,4, Angela Schumich1, Marketa Zaliova2,3,4, Klaus Fortschegger1, Karin Nebral1, Andishe Attarbaschi5, Karel Fiser2,3, Maximilian O Kauer1, Niko Popitsch1, Sabrina Haslinger1, Andrea Inthal1, Barbara Buldini6, Giuseppe Basso6, Jean-Pierre Bourquin7, Giuseppe Gaipa8, Monika Brüggemann9, Tamar Feuerstein10, Margarita Maurer-Granofszky1, Renate Panzer-Grümayer1, Jan Trka2,3,4, Georg Mann5, Oskar A Haas1, Ondrej Hrusak2,3,4, Michael N Dworzak11,5, Sabine Strehl11.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30705095      PMCID: PMC6669149          DOI: 10.3324/haematol.2018.214353

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  13 in total

1.  ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia.

Authors:  M Zaliova; O Zimmermannova; P Dörge; C Eckert; A Möricke; M Zimmermann; J Stuchly; A Teigler-Schlegel; B Meissner; R Koehler; C R Bartram; L Karawajew; P Rhein; J Zuna; M Schrappe; G Cario; M Stanulla
Journal:  Leukemia       Date:  2013-09-27       Impact factor: 11.528

Review 2.  Prognostic and therapeutic role of CLEC12A in acute myeloid leukemia.

Authors:  Linde M Morsink; Roland B Walter; Gert J Ossenkoppele
Journal:  Blood Rev       Date:  2018-11-01       Impact factor: 8.250

3.  AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia.

Authors:  Michael N Dworzak; Barbara Buldini; Giuseppe Gaipa; Richard Ratei; Ondrej Hrusak; Drorit Luria; Eti Rosenthal; Jean-Pierre Bourquin; Mary Sartor; Angela Schumich; Leonid Karawajew; Ester Mejstrikova; Oscar Maglia; Georg Mann; Wolf-Dieter Ludwig; Andrea Biondi; Martin Schrappe; Giuseppe Basso
Journal:  Cytometry B Clin Cytom       Date:  2017-02-21       Impact factor: 3.058

4.  Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults.

Authors:  Takahiko Yasuda; Shinobu Tsuzuki; Masahito Kawazu; Fumihiko Hayakawa; Shinya Kojima; Toshihide Ueno; Naoto Imoto; Shinji Kohsaka; Akiko Kunita; Koichiro Doi; Toru Sakura; Toshiaki Yujiri; Eisei Kondo; Katsumichi Fujimaki; Yasunori Ueda; Yasutaka Aoyama; Shigeki Ohtake; Junko Takita; Eirin Sai; Masafumi Taniwaki; Mineo Kurokawa; Shinichi Morishita; Masashi Fukayama; Hitoshi Kiyoi; Yasushi Miyazaki; Tomoki Naoe; Hiroyuki Mano
Journal:  Nat Genet       Date:  2016-03-28       Impact factor: 38.330

5.  IKZF1plus Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.

Authors:  Martin Stanulla; Elif Dagdan; Marketa Zaliova; Anja Möricke; Chiara Palmi; Giovanni Cazzaniga; Cornelia Eckert; Geertruy Te Kronnie; Jean-Pierre Bourquin; Beat Bornhauser; Rolf Koehler; Claus R Bartram; Wolf-Dieter Ludwig; Kirsten Bleckmann; Stefanie Groeneveld-Krentz; Denis Schewe; Stefanie V Junk; Laura Hinze; Norman Klein; Christian P Kratz; Andrea Biondi; Arndt Borkhardt; Andreas Kulozik; Martina U Muckenthaler; Giuseppe Basso; Maria Grazia Valsecchi; Shai Izraeli; Britt-Sabina Petersen; Andre Franke; Petra Dörge; Doris Steinemann; Oskar A Haas; Renate Panzer-Grümayer; Hélène Cavé; Richard S Houlston; Gunnar Cario; Martin Schrappe; Martin Zimmermann
Journal:  J Clin Oncol       Date:  2018-03-02       Impact factor: 44.544

6.  Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.

Authors:  Richard C Harvey; Charles G Mullighan; Xuefei Wang; Kevin K Dobbin; George S Davidson; Edward J Bedrick; I-Ming Chen; Susan R Atlas; Huining Kang; Kerem Ar; Carla S Wilson; Walker Wharton; Maurice Murphy; Meenakshi Devidas; Andrew J Carroll; Michael J Borowitz; W Paul Bowman; James R Downing; Mary Relling; Jun Yang; Deepa Bhojwani; William L Carroll; Bruce Camitta; Gregory H Reaman; Malcolm Smith; Stephen P Hunger; Cheryl L Willman
Journal:  Blood       Date:  2010-08-10       Impact factor: 22.113

7.  An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions.

Authors:  E Clappier; M F Auclerc; J Rapion; M Bakkus; A Caye; A Khemiri; C Giroux; L Hernandez; E Kabongo; S Savola; T Leblanc; K Yakouben; G Plat; V Costa; A Ferster; S Girard; O Fenneteau; J M Cayuela; F Sigaux; N Dastugue; S Suciu; Y Benoit; Y Bertrand; J Soulier; H Cavé
Journal:  Leukemia       Date:  2013-09-25       Impact factor: 11.528

8.  Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling.

Authors:  Eng-Juh Yeoh; Mary E Ross; Sheila A Shurtleff; W Kent Williams; Divyen Patel; Rami Mahfouz; Fred G Behm; Susana C Raimondi; Mary V Relling; Anami Patel; Cheng Cheng; Dario Campana; Dawn Wilkins; Xiaodong Zhou; Jinyan Li; Huiqing Liu; Ching-Hon Pui; William E Evans; Clayton Naeve; Limsoon Wong; James R Downing
Journal:  Cancer Cell       Date:  2002-03       Impact factor: 31.743

9.  CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineage.

Authors:  L Slamova; J Starkova; E Fronkova; M Zaliova; L Reznickova; F W van Delft; E Vodickova; J Volejnikova; Z Zemanova; K Polgarova; G Cario; M Figueroa; T Kalina; K Fiser; J P Bourquin; B Bornhauser; M Dworzak; J Zuna; J Trka; J Stary; O Hrusak; E Mejstrikova
Journal:  Leukemia       Date:  2013-11-25       Impact factor: 11.528

10.  Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia.

Authors:  Henrik Lilljebjörn; Rasmus Henningsson; Axel Hyrenius-Wittsten; Linda Olsson; Christina Orsmark-Pietras; Sofia von Palffy; Maria Askmyr; Marianne Rissler; Martin Schrappe; Gunnar Cario; Anders Castor; Cornelis J H Pronk; Mikael Behrendtz; Felix Mitelman; Bertil Johansson; Kajsa Paulsson; Anna K Andersson; Magnus Fontes; Thoas Fioretos
Journal:  Nat Commun       Date:  2016-06-06       Impact factor: 14.919

View more
  9 in total

Review 1.  How advanced are we in targeting novel subtypes of ALL?

Authors:  Charles G Mullighan
Journal:  Best Pract Res Clin Haematol       Date:  2019-10-18       Impact factor: 3.020

Review 2.  Molecular markers in ALL: Clinical implications.

Authors:  Shunsuke Kimura; Charles G Mullighan
Journal:  Best Pract Res Clin Haematol       Date:  2020-06-07       Impact factor: 3.020

Review 3.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.

Authors:  Rita Alaggio; Catalina Amador; Ioannis Anagnostopoulos; Ayoma D Attygalle; Iguaracyra Barreto de Oliveira Araujo; Emilio Berti; Govind Bhagat; Anita Maria Borges; Daniel Boyer; Mariarita Calaminici; Amy Chadburn; John K C Chan; Wah Cheuk; Wee-Joo Chng; John K Choi; Shih-Sung Chuang; Sarah E Coupland; Magdalena Czader; Sandeep S Dave; Daphne de Jong; Ming-Qing Du; Kojo S Elenitoba-Johnson; Judith Ferry; Julia Geyer; Dita Gratzinger; Joan Guitart; Sumeet Gujral; Marian Harris; Christine J Harrison; Sylvia Hartmann; Andreas Hochhaus; Patty M Jansen; Kennosuke Karube; Werner Kempf; Joseph Khoury; Hiroshi Kimura; Wolfram Klapper; Alexandra E Kovach; Shaji Kumar; Alexander J Lazar; Stefano Lazzi; Lorenzo Leoncini; Nelson Leung; Vasiliki Leventaki; Xiao-Qiu Li; Megan S Lim; Wei-Ping Liu; Abner Louissaint; Andrea Marcogliese; L Jeffrey Medeiros; Michael Michal; Roberto N Miranda; Christina Mitteldorf; Santiago Montes-Moreno; William Morice; Valentina Nardi; Kikkeri N Naresh; Yasodha Natkunam; Siok-Bian Ng; Ilske Oschlies; German Ott; Marie Parrens; Melissa Pulitzer; S Vincent Rajkumar; Andrew C Rawstron; Karen Rech; Andreas Rosenwald; Jonathan Said; Clémentine Sarkozy; Shahin Sayed; Caner Saygin; Anna Schuh; William Sewell; Reiner Siebert; Aliyah R Sohani; Reuben Tooze; Alexandra Traverse-Glehen; Francisco Vega; Beatrice Vergier; Ashutosh D Wechalekar; Brent Wood; Luc Xerri; Wenbin Xiao
Journal:  Leukemia       Date:  2022-06-22       Impact factor: 12.883

4.  Relapse-Fated Latent Diagnosis Subclones in Acute B Lineage Leukemia Are Drug Tolerant and Possess Distinct Metabolic Programs.

Authors:  Laura García-Prat; Robert J Vanner; Jeffrey Wintersinger; Esmé Waanders; Stephanie M Dobson; Zhaohui Gu; Jessica McLeod; Olga I Gan; Ildiko Grandal; Debbie Payne-Turner; Michael N Edmonson; Xiaotu Ma; Yiping Fan; Veronique Voisin; Michelle Chan-Seng-Yue; Stephanie Z Xie; Mohsen Hosseini; Sagi Abelson; Pankaj Gupta; Michael Rusch; Ying Shao; Scott R Olsen; Geoffrey Neale; Steven M Chan; Gary Bader; John Easton; Cynthia J Guidos; Jayne S Danska; Jinghui Zhang; Mark D Minden; Quaid Morris; Charles G Mullighan; John E Dick
Journal:  Cancer Discov       Date:  2020-02-21       Impact factor: 39.397

Review 5.  Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia.

Authors:  Hiroto Inaba; Ching-Hon Pui
Journal:  J Clin Med       Date:  2021-04-29       Impact factor: 4.241

6.  Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL.

Authors:  Elisabeth Paietta; Kathryn G Roberts; Victoria Wang; Zhaohui Gu; Georgina A N Buck; Deqing Pei; Cheng Cheng; Ross L Levine; Omar Abdel-Wahab; Zhongshan Cheng; Gang Wu; Chunxu Qu; Lei Shi; Stanley Pounds; Cheryl L Willman; Richard Harvey; Janis Racevskis; Jan Barinka; Yanming Zhang; Gordon W Dewald; Rhett P Ketterling; David Alejos; Hillard M Lazarus; Selina M Luger; Letizia Foroni; Bela Patel; Adele K Fielding; Ari Melnick; David I Marks; Anthony V Moorman; Peter H Wiernik; Jacob M Rowe; Martin S Tallman; Anthony H Goldstone; Charles G Mullighan; Mark R Litzow
Journal:  Blood       Date:  2021-09-16       Impact factor: 25.476

Review 7.  Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children.

Authors:  Monika Lejman; Aleksandra Chałupnik; Zuzanna Chilimoniuk; Maciej Dobosz
Journal:  Int J Mol Sci       Date:  2022-03-02       Impact factor: 5.923

Review 8.  The Biology of B-Progenitor Acute Lymphoblastic Leukemia.

Authors:  Kathryn G Roberts; Charles G Mullighan
Journal:  Cold Spring Harb Perspect Med       Date:  2020-07-01       Impact factor: 5.159

9.  High CD34 surface expression in BCP-ALL predicts poor induction therapy response and is associated with altered expression of genes related to cell migration and adhesion.

Authors:  Signe Modvig; Rasmus Wernersson; Nina Friesgaard Øbro; Lars Rønn Olsen; Claus Christensen; Susanne Rosthøj; Matilda Degn; Gitte Wullf Jürgensen; Hans O Madsen; Birgitte Klug Albertsen; Peder Skov Wehner; Steen Rosthøj; Henrik Lilljebjörn; Thoas Fioretos; Kjeld Schmiegelow; Hanne Vibeke Marquart
Journal:  Mol Oncol       Date:  2022-04-07       Impact factor: 7.449

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.